1Department of Neurosurgery, University of Nebraska Medical Center, Omaha, Nebraska.
2Department of Surgery, Division of Neurosurgery and Spine Program, University of Toronto, Ontario, Canada.
J Neurosurg Spine. 2023 Aug 18;39(6):815-821. doi: 10.3171/2023.6.SPINE23461. Print 2023 Dec 1.
The goal of this study was to determine the effect of the degree of frailty on long-term neurological and functional outcomes after surgery for degenerative cervical myelopathy (DCM).
A combined database of patients enrolled in the Cervical Spondylotic Myelopathy-North America and Cervical Spondylotic Myelopathy-International prospective international multicenter observational studies who underwent surgery for DCM was used as the source data. All patients underwent baseline and follow-up assessment at 2 years after surgery for functional, disability, and quality of life measurements (modified Japanese Orthopaedic Association [mJOA] scale, Neck Disability Index, SF-36 physical and mental component summary scores). Patients were separated into 4 groups according to their baseline modified frailty index 5-point scale score: not frail, pre-frail, frail, and severely frail. Differences among groups were analyzed at baseline and at 2 years after surgery, including change in scores (delta values) and the odds ratio of achieving the minimum clinically important difference (MCID) through univariate and multivariable logistic regression adjusting for age, approach, number of levels treated, and sex.
A total of 757 patients (63% male) with a mean age of 56 (95% CI 55.5-57.2) years were included: 470 patients underwent an anterior approach, 310 had a posterior approach, and 23 had a combined anterior/posterior approach. A total of 50% (n = 378) of patients were classified as not frail, with 33% (n = 250) pre-frail, 13% (n = 101) frail, and 4% (n = 28) severely frail. The baseline mJOA score was significantly lower with increasing frailty (14.00 [95% CI 13.75-14.19] for not frail vs 9.71 [95% CI 9.01-10.42] for severely frail patients; p < 0.05), but the change at 2 years was not significantly different among all groups (2.43 [95% CI 2.16-2.71] for not frail vs 2.56 [95% CI 1.10-4.02] for severely frail). The SF-36 delta values were also not different among groups, but significantly worse at baseline with increasing frailty. The odds ratio of achieving MCID for mJOA was significantly higher in the not frail group (1.89 [95% CI 1.36-2.61]; p < 0.05) compared to the other frailty cohorts, which remained after adjusting for age, approach, levels treated, and sex. The odds ratio of achieving MCID for the SF-36 domains was similar among all frailty groups.
Increasing frailty is associated with worse baseline functional and quality of life measures in patients undergoing surgery for DCM. Frailty does not affect the magnitude of improvement in outcome measures after surgery, but reduces the chance of achieving the MCID for functional impairment significantly. Preoperative frailty assessment can therefore help guide clinicians in managing expectations after surgery for DCM. Potentially modifiable factors should be optimized in frail patients preoperatively to enhance functional outcomes.
本研究旨在探讨术前衰弱程度对退行性颈椎脊髓病(DCM)患者手术后长期神经和功能预后的影响。
本研究使用了纳入北美颈椎脊髓病研究(Cervical Spondylotic Myelopathy-North America,CSM-NA)和国际颈椎脊髓病研究(Cervical Spondylotic Myelopathy-International,CSM-I)前瞻性国际多中心观察性研究的患者合并数据库作为原始数据。所有患者在 DCM 手术后 2 年进行功能、残疾和生活质量(改良日本骨科协会[mJOA]量表、颈部残疾指数、SF-36 身心成分综合评分)的基线和随访评估。根据基线改良衰弱指数五分制评分,患者被分为 4 组:无衰弱、衰弱前期、衰弱和严重衰弱。分析各组在基线和手术后 2 年的差异,包括评分变化(差值)和通过单变量和多变量逻辑回归调整年龄、手术入路、治疗节段数和性别后达到最小临床重要差异(MCID)的比值比。
共纳入 757 例(63%为男性)患者,平均年龄为 56 岁(95%置信区间为 55.5-57.2):470 例患者接受前路手术,310 例患者接受后路手术,23 例患者接受前路/后路联合手术。50%(n=378)的患者被归类为无衰弱,33%(n=250)为衰弱前期,13%(n=101)为衰弱,4%(n=28)为严重衰弱。随着衰弱程度的增加,基线 mJOA 评分明显降低(无衰弱组为 14.00[95%置信区间为 13.75-14.19],严重衰弱组为 9.71[95%置信区间为 9.01-10.42];p<0.05),但所有组在 2 年时的变化没有显著差异(无衰弱组为 2.43[95%置信区间为 2.16-2.71],严重衰弱组为 2.56[95%置信区间为 1.10-4.02])。各组 SF-36 差值也没有差异,但随着衰弱程度的增加,基线时明显更差。mJOA 达到 MCID 的比值比在无衰弱组明显更高(1.89[95%置信区间为 1.36-2.61];p<0.05),与其他衰弱队列相比,这一结果在调整年龄、手术入路、治疗节段数和性别后仍然存在。SF-36 各域达到 MCID 的比值比在所有衰弱组之间相似。
在接受 DCM 手术的患者中,衰弱程度的增加与基线时功能和生活质量的下降相关。衰弱程度不会影响手术后结果测量的改善幅度,但会显著降低达到功能障碍 MCID 的机会。因此,术前衰弱评估可以帮助指导临床医生管理 DCM 手术后的预期。应在术前优化衰弱患者的潜在可改变因素,以提高其功能预后。